# Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine

> **NCT06209398** · PHASE4 · UNKNOWN · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 510 (actual)

## Conditions studied

- Hand, Foot and Mouth Disease

## Interventions

- **BIOLOGICAL:** Enterovirus Type 71 Vaccine, inactivated ( Human Diploid Cell )
- **BIOLOGICAL:** Recombinant Hepatitis B Vaccine
- **BIOLOGICAL:** Group A meningococcal polysaccharide vaccine

## Key facts

- **NCT ID:** NCT06209398
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-24
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 510 (ACTUAL)
- **Last updated:** 2024-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06209398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06209398, "Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06209398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*